Thermo Fisher Gets Expansion Of EUA For TaqPath COVID-19 Combo Kit - Quick Facts

(RTTNews) - Thermo Fisher Scientific Inc. (TMO) said Monday it has received an expansion of its Emergency Use Authorization or EUA for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a digital health testing company.

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit. This will enable individuals to self-collect nasal swab specimens after it is determined by a healthcare provider to be appropriate, based on results of a COVID-19 questionnaire.

Samples collected using the Everlywell self-collection kit may be processed by CLIA-certified laboratories running Thermo Fisher's TaqMan SARS-CoV-2 RNase P Assay Kit. The results can be obtained through the Everlywell online platform.

"As part of our commitment to keep our workplaces safe and healthy, Thermo Fisher launched its own pilot program to provide at-home collection kits and online access to test results for more than 10,000 colleagues across the country. Now, leveraging Everlywell's capabilities, we can expand our own use and offer other organizations the confidence to move forward with return-to-workplace strategies that reduce the risk of spreading the virus," said Mark Stevenson, executive vice president and chief operating officer at Thermo Fisher Scientific.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More